BIOREC S.A.
Patent Owner
Stats
- 5 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Nov 29, 2016 most recent publication
Details
- 5 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6 Total Citation Count
- Feb 28, 2007 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9505830 Recombinant antibodies to the vascular endothelial growth factor (VEGF) which are obtained by means of mutagenesis of variable regionsDec 26, 11Nov 29, 16[A61K, C07K]
9278118 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugsOct 20, 14Mar 08, 16[A61K, C07K]
9226946 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugsSep 19, 14Jan 05, 16[A61K, C07K]
9205130 Orally administrable pharmaceutical pellet of epidermal growth factorFeb 10, 11Dec 08, 15[A61K, B05D, A61P]
8871725 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugsFeb 28, 07Oct 28, 14[A61K, A61P, C07K]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.